Free Trial

ICU Medical (NASDAQ:ICUI) Stock Rating Lowered by Wall Street Zen

ICU Medical logo with Medical background

Key Points

  • Wall Street Zen has dropped the rating of ICU Medical from "buy" to "hold," signaling a more cautious outlook for the stock.
  • ICU Medical's recent earnings report showed EPS of $2.10, exceeding the consensus estimate, but overall revenue has decreased by 8% year-over-year.
  • Institutional investors have made significant changes to their holdings, with several firms increasing their positions by over 800% in recent quarters.
  • Looking to export and analyze ICU Medical data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

ICU Medical (NASDAQ:ICUI - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued to investors on Saturday.

Other analysts have also recently issued reports about the company. Raymond James Financial lowered their target price on ICU Medical from $187.00 to $180.00 and set a "strong-buy" rating on the stock in a research report on Friday. KeyCorp lowered their target price on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $190.33.

Check Out Our Latest Report on ICU Medical

ICU Medical Stock Up 2.1%

NASDAQ ICUI traded up $2.30 on Friday, hitting $110.40. 300,682 shares of the stock traded hands, compared to its average volume of 260,379. The stock has a 50-day moving average of $129.62 and a 200 day moving average of $139.55. ICU Medical has a twelve month low of $107.00 and a twelve month high of $196.26. The company has a market capitalization of $2.73 billion, a P/E ratio of -72.63 and a beta of 0.88. The company has a current ratio of 2.44, a quick ratio of 1.17 and a debt-to-equity ratio of 0.63.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.44 by $0.66. The firm had revenue of $543.57 million for the quarter, compared to analysts' expectations of $543.33 million. ICU Medical had a positive return on equity of 7.24% and a negative net margin of 1.56%. ICU Medical's revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.56 earnings per share. As a group, analysts expect that ICU Medical will post 4.11 earnings per share for the current fiscal year.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, Director Elisha W. Finney sold 600 shares of the stock in a transaction on Monday, May 19th. The stock was sold at an average price of $138.92, for a total transaction of $83,352.00. Following the completion of the transaction, the director directly owned 3,252 shares of the company's stock, valued at approximately $451,767.84. This trade represents a 15.58% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Ben Sousa sold 2,000 shares of the stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $137.36, for a total value of $274,720.00. Following the transaction, the insider directly owned 479 shares of the company's stock, valued at approximately $65,795.44. The trade was a 80.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,155 shares of company stock valued at $4,581,168. 1.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On ICU Medical

Several large investors have recently modified their holdings of ICUI. William Blair Investment Management LLC bought a new stake in shares of ICU Medical during the 2nd quarter worth $27,928,000. The Manufacturers Life Insurance Company boosted its stake in shares of ICU Medical by 992.1% during the 1st quarter. The Manufacturers Life Insurance Company now owns 130,762 shares of the medical instruments supplier's stock worth $18,158,000 after acquiring an additional 118,789 shares in the last quarter. MetLife Investment Management LLC boosted its position in shares of ICU Medical by 850.4% in the first quarter. MetLife Investment Management LLC now owns 123,041 shares of the medical instruments supplier's stock worth $17,085,000 after buying an additional 110,095 shares during the period. Ameriprise Financial Inc. boosted its position in shares of ICU Medical by 18.5% in the first quarter. Ameriprise Financial Inc. now owns 693,711 shares of the medical instruments supplier's stock worth $96,326,000 after buying an additional 108,493 shares during the period. Finally, GAMMA Investing LLC boosted its position in shares of ICU Medical by 17,559.7% in the first quarter. GAMMA Investing LLC now owns 99,424 shares of the medical instruments supplier's stock worth $138,060,000 after buying an additional 98,861 shares during the period. 96.10% of the stock is owned by institutional investors.

About ICU Medical

(Get Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Featured Stories

Should You Invest $1,000 in ICU Medical Right Now?

Before you consider ICU Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.

While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines